{"id":46294,"date":"2025-09-27T06:27:15","date_gmt":"2025-09-27T06:27:15","guid":{"rendered":"https:\/\/www.europesays.com\/no\/46294\/"},"modified":"2025-09-27T06:27:15","modified_gmt":"2025-09-27T06:27:15","slug":"helse-sor-ost-sier-opp-avtale-med-privat-leverandor-viser-til-manglende-kontroll","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/no\/46294\/","title":{"rendered":"Helse S\u00f8r-\u00d8st sier opp avtale med privat leverand\u00f8r \u2013 viser til manglende kontroll"},"content":{"rendered":"<p>\n        REAGERER: \u2013 Vi er bekymret for manglende styring og kontroll ved virksomheten, sier Ulrich Spreng, fagdirekt\u00f8r i Helse S\u00f8r-\u00d8st.<br \/>\n        Foto: Julie Kalveland\n    <\/p>\n<p>    Helse S\u00f8r-\u00d8st hevder at Medi3 Oslo har oversett tilfeller av tarmkreft. RHF-et har meldt sakene til Helsetilsynet og sier n\u00e5 opp avtalen med selskapet.<\/p>\n<p>Det regionale helseforetaket skriver i en pressemelding at det er avdekket to tilfeller av oversett tarmkreft ved klinikken.\u00a0<\/p>\n<p>                DM Pluss for helsepersonell<br \/>\n                0 kr<\/p>\n<p class=\"price_description\">Gratis for helsepersonell ved \u00e5 oppgi HPR-nummer.<\/p>\n<p>\n                    <a href=\"https:\/\/api.dagensmedisin.no\/paywall\/order?providerUrl=https%3A%2F%2Fdagensmedisin-s4.azurewebsites.net%2FSalesposter%3FtemplatePackageId%3D6551b878-90ee-479c-8e9a-c4a6dbf76bc3%26PTY%3D9%26ADR%3DOFF%26TAX%3DON%26INV%3DOFF%26HPR%3DREQ%26sourceurl%3D&amp;siteAlias=dagensmedisin&amp;&amp;siteId=2&amp;contentUrl=https%3A%2F%2Fwww.dagensmedisin.no%2Fhelse-sor-ost-rhf-helsetilsynet-kreft%2Fhelse-sor-ost-sier-opp-avtale-med-privat-leverandor-viser-til-manglende-kontroll%2F707744\" rel=\"nofollow noopener\" target=\"_blank\">Registrer deg<\/a>\n                <\/p>\n<p>                DM Pluss49 kr<\/p>\n<p class=\"price_description\">for de f\u00f8rste 30 dagene, deretter 417 kr (eks. MVA) per m\u00e5ned. Ett \u00e5rs bindingstid. Oppsigelse mulig i pr\u00f8veperiode. Betal via kort og Vipps.<\/p>\n<p>\n                    <a href=\"https:\/\/api.dagensmedisin.no\/paywall\/order?providerUrl=https%3A%2F%2Fdagensmedisin-s4.azurewebsites.net%2FSalesposter%3FtemplatePackageId%3Ddfe30ca0-66f7-4281-8c12-6743d6bef834%26PTY%3D2%2C1%26ADR%3DOFF%26TAX%3DON%26INV%3DOFF%26TEL%3DREQ%26sourceurl%3D&amp;siteAlias=dagensmedisin&amp;&amp;siteId=2&amp;contentUrl=https%3A%2F%2Fwww.dagensmedisin.no%2Fhelse-sor-ost-rhf-helsetilsynet-kreft%2Fhelse-sor-ost-sier-opp-avtale-med-privat-leverandor-viser-til-manglende-kontroll%2F707744\" rel=\"nofollow noopener\" target=\"_blank\">Registrer deg<\/a>\n                <\/p>\n<p>                Bedriftsabonnement<\/p>\n<p class=\"price_description\">Ta kontakt med oss s\u00e5 skreddersyr vi l\u00f8sning for deg og din bedrift.<\/p>\n<p>\n                    <a href=\"https:\/\/www.dagensmedisin.no\/dm-pluss-abonnement\" rel=\"nofollow noopener\" target=\"_blank\">Les mer<\/a>\n                <\/p>\n","protected":false},"excerpt":{"rendered":"REAGERER: \u2013 Vi er bekymret for manglende styring og kontroll ved virksomheten, sier Ulrich Spreng, fagdirekt\u00f8r i Helse&hellip;\n","protected":false},"author":2,"featured_media":46295,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[20,21,24,25,15,22,23,13,30,28,29,14,16,26,27],"class_list":{"0":"post-46294","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-norge","8":"tag-breaking-news","9":"tag-breakingnews","10":"tag-featured-news","11":"tag-featurednews","12":"tag-headlines","13":"tag-latest-news","14":"tag-latestnews","15":"tag-news","16":"tag-no","17":"tag-norge","18":"tag-norway","19":"tag-nyheter","20":"tag-overskrifter","21":"tag-top-stories","22":"tag-topstories"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/posts\/46294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/comments?post=46294"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/posts\/46294\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/media\/46295"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/media?parent=46294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/categories?post=46294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/no\/wp-json\/wp\/v2\/tags?post=46294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}